EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Peptide therapy of sleep disorder in neurotized rats


Zhurnal Vysshei Nervnoi Deyatel'nosti Imeni I P Pavlova 33(3): 493-499
Peptide therapy of sleep disorder in neurotized rats
As a result of chronic stress, anxiety appeared in rat behavior, motor activity increased, heart rate, quickened blood pressure raised, conditioned instrumental alimentary reflexes missed, the duration of deep phases of sleep lowered, time of falling asleep became longer, the number of awakening increased. The change in quantitative characteristics of sleep was accompanied by its worsening, especially of rapid sleep. Administration of 250 .mu.g/kg of both substance P (SP) and eledoisin hexapeptide (EH), 100-200 .mu.g/kg of delta sleep peptide and 10 .mu.g/kg of ethylcrotil barbiturate improved the rats behavior and sleep parameters. Calypnon accelerated falling asleep. Delta sleep inducing peptide increased sleep duration. SP and EH restored not only the quantitative characteristics of deep phases of sleep but greatly improved their quality: lowered the blood pressure disrupted tachycardia, normalized the conditioned activity.

(PDF 0-2 workdays service: $29.90)

Accession: 006079955



Related references

Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. An American Academy of Sleep Medicine review. Sleep 30(11): 1484-1501, 2007

Peptide therapy of sleep disorders in neurotic rats. Zhurnal Vysshei Nervnoi Deiatelnosti Imeni i P Pavlova 33(3): 493-499, 1983

Sleep latency and duration estimates among sleep disorder patients: variability as a function of sleep disorder diagnosis, sleep history, and psychological characteristics. Sleep 23(1): 71-79, 2000

Circadian rhythm sleep disorders: Part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. Sleep (Rochester) 30(11): 1484-1501, 2007

Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An Update for 2015: An American Academy of Sleep Medicine Clinical Practice Guideline. Journal of Clinical Sleep Medicine 11(10): 1199-1236, 2016

Effects of repeated delta sleep inducing peptide and delta sleep inducing peptide analog administration on the circadian loco motor activity of rats. Pharmacology Biochemistry & Behavior 15(5): 717-722, 1981

Delta sleep inducing peptide delta sleep inducing peptide phosphorylated analog and circadian motor activity of rats under continuous light. Peptides (New York) 3(4): 623-626, 1982

The delta-sleep inducing peptide (DSIP) increases duration of sleep in rats. Neuroscience Letters 13(2): 169-172, 1979

Increased sleep following intracerebroventricular injection of the delta sleep-inducing peptide in rats. Neuroscience Letters 40(2): 145-149, 1983

The delta sleep inducing peptide increases duration of sleep in rats. Neuroscience Letters 13(2): 169-172, 1979